(Q46934841)

English

Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study

scientific article published on 8 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

14

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

author name string

Cristina Opasich

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Alessandro Boccanelli

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Massimo Cafiero

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Vincenzo Cirrincione

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Donatella Del Sindaco

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Andrea Di Lenarda

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Silvia Di Luzio

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Pompilio Faggiano

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Maria Frigerio

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Donata Lucci

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Maurizio Porcu

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Giovanni Pulignano

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Marino Scherillo

13

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

Aldo P Maggioni

15

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

BRING-UP 2 Investigators

16

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

publication date

8 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

649-657

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Beta blockers in older persons with heart failure: tolerability and impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Beta-blocker benefit according to severity of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Improving Guideline Adherence

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.11.005

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.11.005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16466962

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46934841&oldid=2138521748"